GERSHICK STEVEN 4
4 · NURX PHARMACEUTICALS, INC. · Filed Mar 10, 2009
Insider Transaction Report
Form 4
GERSHICK STEVEN
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2009-03-06+250,000→ 250,000 totalExercise: $0.45→ Common Stock (250,000 underlying)
Footnotes (2)
- [F1]Option vests ratably over 36 months from date of grant 3-6-09.
- [F2]Stock option expires on March 6, 2014, subject to automatic extension if Reporting Person is still employed by the Issuer on such date.